Award of an order to an independent scientific institution to support and evaluate the testing of "amyloid positron emission tomography in dementia of unclear etiology"

The trial is intended to provide insights into answering the question of whether the changes in diagnosis and management made on the basis of an amyloid PET examination in patients with dementia of unclear etiology lead to advantages that suggest a patient-relevant benefit of amyloid PET let (superiority question).